Pages that link to "Q31825740"
Jump to navigation
Jump to search
The following pages link to Effect of oral postmenopausal hormone replacement on progression of atherosclerosis : a randomized, controlled trial (Q31825740):
Displaying 50 items.
- Hormone therapy for preventing cardiovascular disease in post-menopausal women (Q24187326) (← links)
- Hormone therapy for preventing cardiovascular disease in post-menopausal women (Q24197712) (← links)
- Long term hormone therapy for perimenopausal and postmenopausal women (Q24201974) (← links)
- Long term hormone therapy for perimenopausal and postmenopausal women (Q24241279) (← links)
- Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women (Q24244146) (← links)
- Long term hormone therapy for perimenopausal and postmenopausal women (Q24246577) (← links)
- Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society (Q24658109) (← links)
- Pharmacology of estrogens and progestogens: influence of different routes of administration (Q28268346) (← links)
- Long-term hormone therapy for perimenopausal and postmenopausal women (Q30238978) (← links)
- Hormone replacement therapy and secondary cardiovascular prevention: a meta-analysis of randomized trials (Q33222171) (← links)
- The relationship of menopausal status and rapid menopausal transition with carotid intima-media thickness progression in women: a report from the Los Angeles Atherosclerosis Study. (Q34113174) (← links)
- The 2012 Hormone Therapy Position Statement of The North American Menopause Society (Q34161400) (← links)
- Postmenopausal oestrogen replacement therapy and atherosclerosis: can current compounds provide cardiovascular protection? (Q34232000) (← links)
- Assessing the role of oestrogen in the prevention of cardiovascular disease (Q34329552) (← links)
- Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease (Q34375771) (← links)
- The mechanisms of thrombotic risk induced by hormone replacement therapy (Q34421664) (← links)
- Postmenopausal hormone replacement therapy as antiatherosclerotic therapy (Q34482151) (← links)
- Atherosclerosis imaging methods: assessing cardiovascular disease and evaluating the role of estrogen in the prevention of atherosclerosis (Q34707888) (← links)
- Vasomotor and vascular effects of hormone replacement therapy (Q34727147) (← links)
- Antiatherosclerosis interventions in women (Q34727160) (← links)
- Hormone therapy and the cardiovascular system (Q34935018) (← links)
- Efficacy of female rat models in translational cardiovascular aging research (Q34958259) (← links)
- What is the cardioprotective role of hormone replacement therapy? (Q35058238) (← links)
- The menopause and HRT. Hormone replacement therapy, cardiovascular and cerebrovascular disease. (Q35134598) (← links)
- Evidence-based management of dyslipidemias in women (Q35197119) (← links)
- Impact of female hormones on blood pressure: Review of potential mechanisms and clinical studies (Q35574191) (← links)
- Vascular Effects of Estrogenic Menopausal Hormone Therapy (Q35583311) (← links)
- The association between soy nut consumption and decreased menopausal symptoms (Q35590304) (← links)
- Role of the estrogen and progestin in hormonal replacement therapy on apolipoprotein A-I kinetics in postmenopausal women (Q35590308) (← links)
- Postmenopausal hormone therapy: impact on menopause-related symptoms, chronic disease and quality of life (Q35732023) (← links)
- Hormone replacement therapy and cardiovascular disease: lessons from a monkey model of postmenopausal women (Q35757554) (← links)
- Pharmacologic treatment of type 2 diabetic dyslipidemia (Q35976827) (← links)
- Hormone replacement therapy and peripheral vascular disease in women (Q35981132) (← links)
- Hormone replacement therapy, selective estrogen receptor modulators, and tissue-specific compounds: cardiovascular effects and clinical implications (Q36059933) (← links)
- Clinical appraisal of the Women's Health Initiative (Q36072505) (← links)
- Common carotid artery diameter and cardiovascular risk factors in overweight or obese postmenopausal women (Q36203988) (← links)
- Oestrogen and stroke in women: assessment of risk (Q36292523) (← links)
- Estrogen and hypertension (Q36590813) (← links)
- Hormone therapy and cardiovascular disease (Q36686804) (← links)
- The timing hypothesis: Do coronary risks of menopausal hormone therapy vary by age or time since menopause onset? (Q36806086) (← links)
- Effects of tibolone on the breast of postmenopausal women (Q36885708) (← links)
- Standard and low-dose hormone therapy for postmenopausal women--focus on the breast (Q36885714) (← links)
- Post menopausal hormones and measures of subclinical atherosclerosis: the multi-ethnic study of atherosclerosis (Q36945220) (← links)
- Postmenopausal hormone therapy and cardiovascular disease in perspective (Q37234323) (← links)
- Changes in remnant and high-density lipoproteins associated with hormone therapy and progression of coronary artery disease in postmenopausal women (Q37237180) (← links)
- Progesterone enhances vascular endothelial cell migration via activation of focal adhesion kinase. (Q37295760) (← links)
- Overweight and effect of hormone replacement therapy on lipid profiles in postmenopausal women (Q37477171) (← links)
- Hormone therapy and cardiovascular risk markers and disease: focus on progestagens (Q37608577) (← links)
- Complexities of oestrogen in stroke (Q37650744) (← links)
- Attenuation of rate of change in carotid intima-media thickness by lipid-modifying drugs: impact on clinical outcomes. (Q37886975) (← links)